2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1093119554 M.D.
Verify on CMS →

Francesco Vendrame, M.D.

Endocrinology, Diabetes & Metabolism Physician in Miami, Florida.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,078 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 395 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
40%
generic claims · 52% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.5 · Exceptional

What the federal data shows

Francesco Vendrame, M.D. reported a CMS MIPS final score of 100/100 - above the 83.5 national average - and filed 2,930 Medicare Part D claims in 2024.

100/100
MIPS score · +17 vs avg
3K
Part D claims, 2024
40%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Francesco Vendrame, M.D.

Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1093119554), first enumerated 10/13/2014.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 2,930 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    CMS quality reporting (MIPS)

    Reported a CMS MIPS final score of 100/100 in the Quality Payment Program — a federal quality measure, not a patient review.

    Source: CMS Quality Payment Program

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • State context

    State board disciplinary context

    Florida statewide board action statistics are published annually — these figures describe aggregate state activity, not Francesco Vendrame, M.D.'s individual license status. Verify directly with the state medical board.

    Source: FLDOH annual report 2023

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1093119554 · Endocrinology, Diabetes & Metabolism Physician

NPI-10 · ENUM-MID · TAX-MID · MIPS-ELITE · RX-MID · BOOK-LIGHT · PHOTO-FINISH

  • NPI-10 1093119554
  • ENUM-MID 2014
  • TAX-MID 8K Endocrinology, Diabetes
  • MIPS-ELITE 100/100
  • RX-MID 2,930
  • BOOK-LIGHT 538 in Florida
  • PHOTO-FINISH Smita Abraham · ±0.0

MIPS final-score neighbourhood

Same-specialty nationwide peers by CMS final score, not geographic proximity

MIPS pts

What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).

Source CMS Quality Payment Program (MIPS) As of 2023

Francesco Vendrame, M.D.'s MIPS score vs every measured U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.

100 ≥ 92nd percentile 92% of 454,083 measured providers are in lower value bands

0–10: 8,684 measured providers (2%). Below this entry. 10–20: 3,008 measured providers (1%). Below this entry. 20–30: 3,069 measured providers (1%). Below this entry. 30–40: 2,746 measured providers (1%). Below this entry. 40–50: 2,928 measured providers (1%). Below this entry. 50–60: 5,882 measured providers (1%). Below this entry. 60–70: 13,906 measured providers (3%). Below this entry. 70–80: 94,570 measured providers (21%). Below this entry. 80–90: 129,887 measured providers (29%). Below this entry. 90+: 189,403 measured providers (42%). This entry sits in this band. This provider 0 100 every measured MIPS clinician, bucketed by value

Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Francesco Vendrame, M.D. sits

This provider among endocrinology, diabetes & metabolism physician peers

Across the 2,341 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Francesco Vendrame, M.D. writes more Part D claims than 59% of them and scores higher on MIPS quality than 93% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality02550751000255075100Part D claim volume, percentile in specialtyMIPS quality, percentilePoint, Part D claim volume, percentile in specialty: 45 · MIPS quality, percentile: 78Point, Part D claim volume, percentile in specialty: 63 · MIPS quality, percentile: 75Point, Part D claim volume, percentile in specialty: 70 · MIPS quality, percentile: 68Point, Part D claim volume, percentile in specialty: 80 · MIPS quality, percentile: 40Point, Part D claim volume, percentile in specialty: 30 · MIPS quality, percentile: 50Point, Part D claim volume, percentile in specialty: 53 · MIPS quality, percentile: 57Point, Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 23Point, Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 40Point, Part D claim volume, percentile in specialty: 7 · MIPS quality, percentile: 93Point, Part D claim volume, percentile in specialty: 12 · MIPS quality, percentile: 23Point, Part D claim volume, percentile in specialty: 85 · MIPS quality, percentile: 32Point, Part D claim volume, percentile in specialty: 97 · MIPS quality, percentile: 65Point, Part D claim volume, percentile in specialty: 20 · MIPS quality, percentile: 85Point, Part D claim volume, percentile in specialty: 47 · MIPS quality, percentile: 3Point, Part D claim volume, percentile in specialty: 65 · MIPS quality, percentile: 35Point, Part D claim volume, percentile in specialty: 37 · MIPS quality, percentile: 47Point, Part D claim volume, percentile in specialty: 87 · MIPS quality, percentile: 77Point, Part D claim volume, percentile in specialty: 23 · MIPS quality, percentile: 13Point, Part D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 90Point, Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 97Point, Part D claim volume, percentile in specialty: 50 · MIPS quality, percentile: 12Point, Part D claim volume, percentile in specialty: 83 · MIPS quality, percentile: 22Point, Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 97Point, Part D claim volume, percentile in specialty: 92 · MIPS quality, percentile: 67Point, Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 52 · MIPS quality, percentile: 88Point, Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 7Point, Part D claim volume, percentile in specialty: 57 · MIPS quality, percentile: 60Point, Part D claim volume, percentile in specialty: 3 · MIPS quality, percentile: 20Point, Part D claim volume, percentile in specialty: 42 · MIPS quality, percentile: 5Point, Part D claim volume, percentile in specialty: 58 · MIPS quality, percentile: 48Point, Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 53Point, Part D claim volume, percentile in specialty: 77 · MIPS quality, percentile: 33Point, Part D claim volume, percentile in specialty: 60 · MIPS quality, percentile: 72Point, Part D claim volume, percentile in specialty: 62 · MIPS quality, percentile: 45Point, Part D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 82Point, Part D claim volume, percentile in specialty: 32 · MIPS quality, percentile: 38Point, Part D claim volume, percentile in specialty: 98 · MIPS quality, percentile: 55Point, Part D claim volume, percentile in specialty: 73 · MIPS quality, percentile: 82Point, Part D claim volume, percentile in specialty: 88 · MIPS quality, percentile: 70Point, Part D claim volume, percentile in specialty: 10 · MIPS quality, percentile: 18Point, Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 95Point, Part D claim volume, percentile in specialty: 93 · MIPS quality, percentile: 28Point, Part D claim volume, percentile in specialty: 43 · MIPS quality, percentile: 63Point, Part D claim volume, percentile in specialty: 5 · MIPS quality, percentile: 37Point, Part D claim volume, percentile in specialty: 68 · MIPS quality, percentile: 27Point, Part D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 78Point, Part D claim volume, percentile in specialty: 95 · MIPS quality, percentile: 10Point, Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 30Point, Part D claim volume, percentile in specialty: 18 · MIPS quality, percentile: 87Point, Part D claim volume, percentile in specialty: 75 · MIPS quality, percentile: 43Point, Part D claim volume, percentile in specialty: 48 · MIPS quality, percentile: 62Point, Part D claim volume, percentile in specialty: 82 · MIPS quality, percentile: 52Point, Part D claim volume, percentile in specialty: 90 · MIPS quality, percentile: 73Point, Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 0Point, Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 2Point, Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 58Point, Part D claim volume, percentile in specialty: 8 · MIPS quality, percentile: 17Point, Part D claim volume, percentile in specialty: 27 · MIPS quality, percentile: 8Point, Part D claim volume, percentile in specialty: 15 · MIPS quality, percentile: 15Francesco Vendrame, M.D., Part D claim volume, percentile in specialty: 59 · MIPS quality, percentile: 93
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Francesco Vendrame, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

Board certification likely (heuristic, not verified)

Francesco Vendrame, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Francesco Vendrame, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 10/13/2014

NPI 1093119554

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

8,078 US NPIs in this specialty

Medicare Part D claims

2,930 7% vs specialty avg

2024 prescription claims

Specialty avg: 2,739

MIPS final score

100/100 16.5 pts vs avg

Exceptional band

vs 83.5 national avg

Specialty distribution in Florida

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers

Florida providers
Behavior Technician16.3%Mental Health Counselor4.8%Family Nurse Practitioner4.5%Pharmacist4.1%Student in an Organized Heal…4.1%Physical Therapist3%Endocrinology, Diabetes & Me…0.1%
Largest specialties in Florida (% of in-state providers)

Medicare quality performance, MIPS

Francesco Vendrame, M.D.'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

High performer (top quartile)
MIPS Final Score
100/100
vs 83.5 national avg · 2023 performance year
0%100%National avg84%99%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) - 100/100 vs national avg 83.5
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

1400 NW 10TH AVE STE 805
Miami, FL 33136

Provider Details

NPI 1093119554
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials M.D.
Gender Male
NPI Issued 10/13/2014

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

100
Final Score
Measured-score avg: 83.5
87.7206
Quality
100
Promoting Interoperability

Reporting: Individual

Hospital and facility affiliations

Facilities where Francesco Vendrame, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

University OF Miami
Miami, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context - Florida FLDOH 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Francesco Vendrame, M.D.. To verify Francesco Vendrame, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

Francesco Vendrame, M.D. - brand share 52.0%
Endocrinology, Diabetes & Metabolism Physician average

52% brand-name claims vs 40% generic, on 2,930 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

2,930
Total Claims
$1.5M
Total Drug Cost
395
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
6,585.367
Total Day Supply
195,214
Brand vs Generic
52% brand / 40% generic
Brand Drug Cost
$1.4M
Generic Drug Cost
$23K

Patient Demographics

Average Patient Age
68.5 years
Avg HCC Risk Score
2.03
Gender Split
53% female / 47% male
Age Distribution
<65: 77, 65-74: 210, 75-84: 94, 85+: 14

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Francesco Vendrame, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Ozempic
Semaglutide
350
Levothyroxine Sodium
154
Metformin Hcl Er
Metformin Hcl
148
Trulicity
Dulaglutide
142
Metformin Hcl
140
Atorvastatin Calcium
135
Jardiance
Empagliflozin
125
Lantus Solostar
Insulin Glargine,hum.Rec.Anlog
118
Rosuvastatin Calcium
103
Glipizide
86

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How Francesco Vendrame, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

8,078
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,739
Avg Claims per Provider

Francesco Vendrame, M.D.'s 2,930 claims are above the specialty average of 2,739.

Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Vendrame, both outside Florida so the neighborhoods are not geographic containment.

Similar MIPS final score

Nearest same-specialty clinicians by CMS MIPS final score (100 here).

Same NPPES enumeration year (2014)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Vendrame.

One of 538 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Florida, 5 are shown here.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Francesco Vendrame, M.D.'s specialty?
Francesco Vendrame, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Miami, Florida. Credentials: M.D..
How much does Francesco Vendrame, M.D. prescribe under Medicare Part D?
In 2024, Francesco Vendrame, M.D. wrote 2,930 Medicare Part D claims totaling $1.5M in drug costs for 395 beneficiaries.
What is Francesco Vendrame, M.D.'s Medicare quality score?
Francesco Vendrame, M.D. has a CMS MIPS Final Score of 100/100 (Quality: 87.7). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Francesco Vendrame, M.D. located?
Francesco Vendrame, M.D. is located at 1400 NW 10TH AVE STE 805, Miami, FL, 33136. Phone: (305) 243-3636.
What is Francesco Vendrame, M.D.'s NPI number?
Francesco Vendrame, M.D.'s National Provider Identifier (NPI) is 1093119554, issued on 10/13/2014.
Does Francesco Vendrame, M.D. prescribe more brand-name or generic drugs?
Francesco Vendrame, M.D.'s prescribing is 52% brand-name and 40% generic drugs by claim count, with $1.4M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 8,078 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,739 Medicare Part D claims per year.
What drugs does Francesco Vendrame, M.D. prescribe most often?
Based on 2024 Medicare Part D data, Francesco Vendrame, M.D.'s most frequently prescribed drugs include Ozempic, Levothyroxine Sodium, Metformin Hcl Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Francesco Vendrame, M.D. accept Medicare?
Francesco Vendrame, M.D. appears in CMS Medicare data with 2,930 Part D claims and 395 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Francesco Vendrame, M.D.'s credentials?
Francesco Vendrame, M.D.'s NPI is 1093119554 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.